RT Book, Section
A1 Armstrong, Ehrin J.
A1 Laird, John R.
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146605433
T1 Endovascular Therapies for Abdominal Aortic Aneurysm
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146605433
RD 2024/04/23
AB Rupture  of  abdominal  aortic  aneurysms  (AAAs)  accounts  for  over  15,000  deaths  per  year  in  the  United  States  and  is  the  10th  leading  cause  of  death  in  men  older  than  55  years  of  age  (Fig.  56-1).1  Out-of-hospital  AAA  rupture  is  associated  with  a  mortality  of  80%  to  90%.  Most  deaths  are  preventable  by  the  early  diagnosis  and  treatment  of  AAA,  and  as  a  result,  more  than  60,000  surgical  or  endovascular  procedures  for  AAA  are  performed  annually  in  the  United  States.  Despite  the  excellent  results  of  open  surgical  repair  for  the  prevention  of  aneurysm  rupture,  this  procedure  is  associated  with  significant  morbidity  and  mortality,  especially  in  high-risk  patients.  Endovascular  aneurysm  repair  (EVAR),  which  was  developed  as  a  less  invasive  alternative  to  open  surgical  repair,  is  gaining  widespread  acceptance  and  is  now  performed  in  approximately  80%  of  elective  aneurysm  repairs.  This  chapter  reviews  the  epidemiology,  technical  aspects,  outcomes,  and  complications  of  EVAR  for  the  treatment  asymptomatic  and  symptomatic  AAA.